Starpharma Holdings Ltd (SPHRY)
0.90
-0.01
(-1.27%)
USD |
OTCM |
Apr 18, 16:00
Starpharma Holdings Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2013 | -5.312M |
| December 31, 2012 | -10.62M |
| December 31, 2011 | -3.950M |
| December 31, 2010 | -3.815M |
| December 31, 2009 | -1.854M |
| December 31, 2008 | -1.743M |
| December 31, 2007 | -2.527M |
| Date | Value |
|---|---|
| December 31, 2006 | -2.209M |
| December 31, 2005 | -3.469M |
| December 31, 2004 | -2.263M |
| December 31, 2003 | -1.926M |
| December 31, 2002 | -2.642M |
| December 31, 2001 | -2.034M |
| December 31, 2000 | -0.2495M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | -- |
| Mesoblast Ltd | -16.28M |